Location: New York, NY
CIK: 0001831942 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 14, 2024
Total Value: $1.6B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | MERUS N V | 3,350,000 | $167M | 10.5% | $26.27 | — | COM | N5749R100 |
| VERA | VERA THERAPEUTICS INC | 2,475,000 | $109M | 6.8% | $8.35 | +354.4% | CL A | 92337R101 |
| XENE | XENON PHARMACEUTICALS INC | 2,700,000 | $106M | 6.6% | $30.11 | +33.9% | COM | 98420N105 |
| PCVX | VAXCYTE INC | 920,000 | $105M | 6.6% | $53.62 | +68.1% | COM | 92243G108 |
| ELVN | ENLIVEN THERAPEUTICS INC | 4,100,000 | $105M | 6.5% | $18.63 | +24.3% | COM | 29337E102 |
| NUVL | NUVALENT INC | 940,000 | $96.16M | 6.0% | $45.30 | +83.1% | COM | 670703107 |
| COGT | COGENT BIOSCIENCES INC | 7,539,930 | $81.43M | 5.1% | $8.23 | +18.3% | COM | 19240Q201 |
| ALKS | ALKERMES PLC | 2,900,000 | $81.17M | 5.1% | $25.65 | +3.9% | SHS | G01767105 |
| SLNO | SOLENO THERAPEUTICS INC | 1,260,000 | $63.62M | 4.0% | $38.06 | +25.8% | COM | 834203309 |
| SYRE | SPYRE THERAPEUTICS INC | 1,988,084 | $58.47M | 3.7% | $14.79 | +88.3% | COM NEW | 00773J202 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 2,550,124 | $58.02M | 3.6% | $16.71 | -2.2% | COM | 92790C104 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 1,618,937 | $55.03M | 3.4% | $35.24 | +8.1% | COM NEW | 15117B202 |
| — | MIND MEDICINE MINDMED INC | 8,000,000 | $45.52M | 2.8% | $8.64 | — | COM NEW | 60255C885 |
| CATX | PERSPECTIVE THERAPEUTICS INC | 3,350,000 | $44.72M | 2.8% | $14.46 | -8.0% | COM NEW | 46489V302 |
| NRIX | NURIX THERAPEUTICS INC | 1,650,000 | $37.08M | 2.3% | $22.65 | 0.0% | COM | 67080M103 |
| PHVS | PHARVARIS N V | 1,911,433 | $35.4M | 2.2% | $23.20 | -21.2% | COM | N69605108 |
| KURA | KURA ONCOLOGY INC | 1,800,000 | $35.17M | 2.2% | $15.75 | +28.7% | COM | 50127T109 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 650,000 | $34.05M | 2.1% | $24.90 | +92.5% | COM | 76243J105 |
| ORKA | ORUKA THERAPEUTICS INC | 1,369,714 | $33.57M | 2.1% | $34.79 | 0.0% | COM | 687604108 |
| ARVN | ARVINAS INC | 1,200,000 | $29.56M | 1.8% | $29.08 | -10.2% | COM | 04335A105 |
| CELC | CELCUITY INC | 1,522,332 | $22.7M | 1.4% | $18.21 | -9.5% | COM | 15102K100 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 1,350,000 | $21.59M | 1.3% | $15.99 | — | SPONSORED ADS | 152309100 |
| NKTX | NKARTA INC | 4,662,073 | $21.07M | 1.3% | $4.61 | +23.3% | COM | 65487U108 |
| ORIC | ORIC PHARMACEUTICALS INC | 2,000,000 | $20.5M | 1.3% | $11.88 | -16.7% | COM | 68622P109 |
| CCCC | C4 THERAPEUTICS INC | 3,410,384 | $19.44M | 1.2% | $2.28 | +163.9% | COM STK | 12529R107 |
| — | THIRD HARMONIC BIO INC | 1,360,569 | $18.44M | 1.2% | $12.09 | — | COM | 88427A107 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 885,000 | $17.04M | 1.1% | $21.40 | -3.5% | COM | 87164F105 |
| APGE | APOGEE THERAPEUTICS INC | 290,000 | $17.03M | 1.1% | $25.01 | +91.5% | COM | 03770N101 |
| ABVX | ABIVAX SA | 1,284,110 | $14.79M | 0.9% | $10.70 | — | SPONSORED ADS | 00370M103 |
| TIL | INSTIL BIO INC | 150,929 | $10.16M | 0.6% | $23.54 | 0.0% | COM NEW | 45783C200 |
| NGNE | NEUROGENE INC | 200,000 | $8.392M | 0.5% | $33.40 | +16.1% | COM | 64135M105 |
| PCSC | PERCEPTIVE CAP SOLUTIONS COR | 750,000 | $7.508M | 0.5% | $10.07 | -0.1% | CL A ORD SHS | G70077105 |
| BBOT | HELIX ACQUISITION CORP II | 500,000 | $5.225M | 0.3% | $10.35 | +0.1% | CL A ORD SHS | G4444H101 |
| CABA | CABALETTA BIO INC | 1,100,000 | $5.192M | 0.3% | $7.66 | -24.4% | COM | 12674W109 |
| VTGN | VISTAGEN THERAPEUTICS INC | 1,575,000 | $4.741M | 0.3% | $4.44 | -23.1% | COM | 92840H400 |
| AVTX | AVALO THERAPEUTICS INC | 483,000 | $4.588M | 0.3% | $10.53 | -2.1% | COM NEW | 05338F306 |